Our Mission
The International Robotic Transplant Registry - IRTRegistry is a global collaborative initiative dedicated to advancing the field of robotic organ transplantation through:
- Standardized data collection
- Multicenter research
- Evidence-based best practices
The 2024 Minimally Invasive Organ Transplant Consensus Conference - MIOT.cc identified prospective robotic transplant registries as a top priority to accelerate safe global adoption through evidence-based guidelines as well as validate outcomes beyond single-center reports.
By creating the world’s first comprehensive registry for robotic transplant surgery, we aim to:
- Establish benchmarks for safety and efficacy across all organs.
- Identify innovations in robotic techniques.
- Improve patient outcomes through shared knowledge and real-world data.
Why Robotic Transplantation?
The field of organ transplantation is undergoing a technological evolution, with the robotic approach offering:
- Enhanced precision in vascular anastomoses.
- Reduced morbidity compared to open approaches.
- Faster recovery for living donors and recipients.
Yet widespread adoption requires rigorous outcomes tracking, this is where IRTRegistry.org leads.
Scope & Evolution
Current Focus
- Robotic Liver Transplantation (deceased and living donor)
- Future Expansion (2025–2026): Kidney | Pancreas | Lung | Uterus | Heart
Our Methodology
Data Collection
- Standardized reporting metrics for all robotic transplants.
- Prospective and retrospective case inclusion.
- Secure, HIPAA/GDPR-compliant platform.
Research Priorities
- Identification of independent predictors of outcome
- Complication profiles.
- Graft and recipient survival in robotic transplants.
- Learning curve analysis for robotic programs.
- Cost-effectiveness analyses
Leadership & Governance
The IRTRegistry.org is guided by an international steering committee of transplant surgeons, robotic pioneers, and data scientists, under the umbrella of the MIOT.cc Committee. Click here or visit the Team page for the complete list of Team embers
"The IRTRegistry fills a critical gap in transplant innovation—without robust data, progress is anecdotal. This is our chance to shape the future."
- Prof Dieter C. Broering, Founding Committee Member
Collaborators & Endorsements
- We partner with: (to be announced)
Authorship Rules
1. Member Participation
- All IRTRegistry.org committee and members contributing data are eligible for authorship.
- 3 authors (typically: lead surgeon, middle great / data submitter / junior)
+1 local auditor (mandatory; verifies data accuracy) (Max 4)
Exceptions: Approved by the Founding committee.
2. Publications Using Registry Data
- For Member-Led Studies
Authorship decided by study leads (following ICMJE criteria).
Requirement: Include "IRTRegistry.org Collaborative" as group author in PubMed-indexed publications. - For Registry-Wide Studies
Group authorship alone (to reflect the collaborative nature of the registry)
Or Named authors = writing group + IRTRegistry.org Collaborative (PubMed-indexed)
3. Dispute Resolution
- Tool: Authorships.org (binding arbitration).
- Process
Submit conflict by email.
14-day review period.
Committee ruling (final).
4. Compliance
- Non-compliance = temporary data submission freeze.
- Appeals require new evidence submission.
Join the Movement
- The IRTRegistry.org thrives on global participation.
- Contact office@IRTRegistry.org to register your interest.